Patent · US Active

Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent

US8017148B2 · kind B2 · utility

99Cited by
23References
20Claims
0Family size

Assignee

Inventor

Key dates

Filing dateSep 22, 2006
Grant dateSep 13, 2011
Priority date—
Expiry dateMar 10, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/2027
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed in certain embodiments is an oral dosage form comprising:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.